Are you Dr. Joshi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-6704Fax+1 410-328-4124
Summary
- Dr. Manjari Joshi, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is affiliated with University of Maryland Medical Center and is an Associate Professor at University of Maryland School of Medicine.
Education & Training
- University of MarylandFellowship, Infectious Disease, 1981 - 1983
- University of Maryland Capital Region HealthResidency, Internal Medicine, 1977 - 1978
- Medfield State HospitalInternship, Transitional Year, 1976 - 1977
- All India Institute of Medical SciencesClass of 1976
Certifications & Licensure
- MD State Medical License 1979 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Do the results of the OXYGEN trial change if analyzed as "as-treated?": A secondary analysis of the OXYGEN trial.Augustine M Saiz, Anthony R Carlini, Renan C Castillo, Manjari Joshi, Yanjie Huang
Injury. 2024-12-01 - 2 citationsDoes Topical Vancomycin Powder Use in Fracture Surgery Change Bacteriology and Antibiotic Susceptibilities? An Analysis of the VANCO Trial.Manjari Joshi, Robert V O'Toole, Anthony R Carlini, Joshua L Gary, William T Obremskey
Journal of Orthopaedic Trauma. 2024-04-01 - 5 citationsSkin Antisepsis before Surgical Fixation of Extremity Fractures., Sheila Sprague, Gerard Slobogean, Jeffrey L Wells, Nathan N O'Hara
The New England Journal of Medicine. 2024-02-01
Press Mentions
- Principles of Antibiotic Therapy in the Critically IllMay 19th, 2019
- Topical Vancomycin May Alter Bacteriology of SSIJanuary 13th, 2016